Burkitt’s Lymphoma and B-Cell Lymphoma Unclassifiable With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Burkitt’s Lymphoma in Patients With HIV: Outcomes in a South African Public Hospital | Zendy

Gerhard Sissolak | Zendy; Matthew D. Seftel | Zendy; Thomas S. Uldrick | Zendy; Tonya M. Esterhuizen | Zendy; N. Mohamed | Zendy; Danie Kotze | Zendy

Open Access

Burkitt’s Lymphoma and B-Cell Lymphoma Unclassifiable With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Burkitt’s Lymphoma in Patients With HIV: Outcomes in a South African Public Hospital

Author(s) -

Gerhard Sissolak,

Matthew D. Seftel,

Thomas S. Uldrick,

Tonya M. Esterhuizen,

N. Mohamed,

Danie Kotze

Publication year - 2016

Publication title -

journal of global oncology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.002

H-Index - 17

ISSN - 2378-9506

DOI - 10.1200/jgo.2015.002378

Subject(s) - vincristine , medicine , cyclophosphamide , prednisone , lymphoma , chop , diffuse large b cell lymphoma , regimen , gastroenterology , chemotherapy , oncology , immunology

Burkitt's lymphoma (BL) is a common HIV-associated lymphoma in South Africa. B-cell lymphoma unclassifiable with features intermediate between diffuse large B-cell lymphoma and Burkitt's lymphoma (BL/DLBCL) also occurs in HIV infection. Outcomes of HIV-infected patients with BL or BL/DLBCL in a resource-constrained setting are not defined.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research